Bleeding News and Research

RSS

Baxter receives FDA approval for new dosage of Advate for hemophilia A

Baxter Healthcare Corporation announced that the U.S. Food and Drug Administration (FDA) has approved a new 3000 IU (5mL) dosage strength of ADVATE [Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method].

12 Jul 2007

Baxter presents findings from the ADAPT study

Baxter Healthcare Corporation has announced the presentation of findings from the ADAPT (Analysis of Data from ADVATE Prospective Trials) study program database showing a statistically significant relationship between the duration of time spent with factor VIII blood levels below one international unit per deciliter (1 IU/dL, one percent of normal factor VIII level) and an increase in the annual bleed rate in people with hemophilia A.

11 Jul 2007

Bacteria from mouth found in the amniotic fluid of some pregnant women

A study appearing in the July issue of the Journal of Periodontology found bacteria commonly found in the mouth and associated with periodontal diseases in the amniotic fluid of some pregnant women.

4 Jul 2007

Catastrophic head injuries in football dramatically higher at high school level than college level

The incidence of catastrophic head injuries in football is dramatically higher at the high school level than at the college level, according to a study published in the July issue of The American Journal of Sports Medicine.

4 Jul 2007

Bayer and Onyx submit supplemental NDA for Nexavar

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals have announced that a Supplemental New Drug Application (sNDA) for Nexavar (sorafenib) tablets has been submitted to the U.S. Food and Drug Administration (FDA) for the treatment of patients with hepatocellular carcinoma (HCC), the most common form of liver cancer. Nexavar is currently approved in more than 50 countries for the treatment of advanced kidney cancer.

28 Jun 2007

Omega-3 polyunsaturated fatty acids protect against retinopathy

Omega-3 polyunsaturated fatty acids protect against the development and progression of retinopathy, a deterioration of the retina, in mice.

26 Jun 2007

Dutch research project designed to reduce maternal and child mortality

Top Institute Pharma, which carries out pioneering research projects with the support of the Dutch Ministry of Health in order to develop better and safer medicines, is starting a unique research project designed to reduce maternal and child mortality.

20 Jun 2007

Safe blood for safe motherhood

On the occasion of World Blood Donor Day, the theme of which this year is "Safe blood for safe motherhood", WHO is launching a new initiative to improve the availability and use of safe blood to save the lives of women during and after childbirth.

19 Jun 2007

Columbia dentists target chronic oral health problems in sub-Saharan Africa

A new initiative from Columbia University Medical Center will be the first to target chronic oral health problems in sub-Saharan Africa, where the vast majority of chronic diseases are left undetected and untreated.

19 Jun 2007

Clot-buster treatment works in frostbite patients

Researchers in the United States have found that when people with frostbite were treated with a clot-busting drug commonly used to treat stroke patients, fewer amputations resulted.

19 Jun 2007

CryoLife awarded patent for BioFoam

CryoLife has announced that it has been awarded a patent by the U.S. Patent Office for BioFoam, a protein hydrogel foam for rapidly filling and sealing open wounds.

17 Jun 2007

Study shows pre-op red blood cell levels affect post-op outcomes

Men over 65 with even slightly abnormal red blood cell counts either too low or too high are at greater risk of post-operative death or car-diac events following a major non-cardiac surgery, according to a new study by researchers at the Providence Veterans Affairs Medical Center and The Warren Alpert Medical School of Brown University.

15 Jun 2007

Periodontal diseases are a threat to women of all ages

Two new studies in the June issue of the Journal of Periodontology (JOP) suggest that periodontal diseases are a threat to women of all ages due to hormonal fluctuations that occur at various stages of their lives.

15 Jun 2007

Surgery underway to separate twins joined at the head

Neurosurgeons in the U.S. have begun the first of many operations to separate 3-year-old twins who are joined at the head.

7 Jun 2007

breakthrough in the treatment of idiopathic pulmonary haemosiderosis

Researchers at Queen Mary University London and the University of Leicester and have announced a potential breakthrough in the treatment of a rare but devastating medical condition that can affect children and young people.

5 Jun 2007

Breakthrough in idiopathic pulmonary haemosiderosis

3 Jun 2007

FDA approves Norditropin for short stature in children with Noonan syndrome

Novo Nordisk has announced that Norditropin (somatropin[rDNA origin] injection) received U.S. Food and Drug Administration (FDA) approval for the treatment of short stature in children with Noonan syndrome.

3 Jun 2007

Study questions risks of aprotinin during heart surgery

Contrary to recent studies, proper use of a drug called aprotinin to reduce bleeding during heart surgery does not increase the risk of heart attack or stroke, according to a study in the June issue of The Journal of Thoracic and Cardiovascular Surgery.

1 Jun 2007

Proper use of aprotinin to reduce bleeding during heart surgery does not increase the risk of heart attack or stroke

The study was prompted by recent reports suggesting an increased risk of complications including heart attacks, strokes, and kidney problems in patients who received aprotinin to reduce bleeding during heart bypass or valve replacement surgery.

30 May 2007

MRI helps predict recovery after spinal cord injury

Using magnetic resonance imaging (MRI), radiologists can better predict the likelihood of full or partial recovery of patients with acute spinal cord injuries (SCI), according to a study published in the June issue of the journal Radiology.

30 May 2007